Top Markets
Coin of the day
IR-Med Inc. IR-Med Inc.

IR-Med Inc.

IRME
Rank in Stocks #40380
IR-Med Inc. is an emerging medical technology firm dedicated to developing... IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's product pipeline includes PressureSafe, a handheld optical monitoring device engineered for the early identification of pressure-induced tissue damage in the skin and subcutaneous layers, often resulting from extended periods of patient immobility. Additionally, IR-Med is developing Nobiotics, an innovative otoscope designed to provide medical professionals with immediate feedback on the presence of middle ear infections (Otitis Media), a prevalent condition among pediatric patients. IR-Med Inc. operates from its headquarters in Rosh Pina, Israel.
Share Price
$0.0021
Last synced: 2026-08-12
Market Cap
$162.20K
Change (1 day)
0.00%
Change (1 year)
-88.20%
Country
IL
Trade IR-Med Inc. (IRME)

Category

P/S ratio for IR-Med Inc. (IRME)
P/S ratio as of 2026 TTM: 0
According to IR-Med Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for IR-Med Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
3.95 -
US
4.83 -
US
2.78 -
IE
3.31 -
US
7.61 -
US